Dosimetry and preclinical evaluation of long-term radiotoxicity following treatment with 212Pb alpha-radioimmunotherapy targeting CD20
{{output}}
Background: Radioimmunotherapy (RIT) with α-emitters represents an attractive alternative for the treatment of refractory Non-Hodgkin lymphoma (NHL) due to the high linear energy transfer and short path length of α-radiation in... ...
